Heart failure with preserved ejection fraction (HFpEF) is now the most common form of HF,
affecting over 3 million adults in the United States alone. HFpEF is a heterogenous …

Heart failure with preserved ejection fraction (HFpEF) is a heterogeneous disorder
developing from multiple aetiologies with overlapping pathophysiological mechanisms …

Plasma heart failure (HF) biomarkers, like natriuretic peptides, are important in diagnosis,
prognosis and HF treatment. Several novel HF biomarkers have been identified, including …

Heart failure with preserved ejection fraction (HFpEF) has become a major health issue
because of its high mortality, high heterogeneity, and poor prognosis. Using genomic data to …

Heart failure with preserved ejection fraction (HFpEF) is an increasingly prevalent
phenotype affecting over half of today's heart failure patients. With no proven therapy and no …

Background: Endostatin is a circulating endogenous angiogenesis inhibitor preventing
neovascularization. Previous studies demonstrated the prognostic value of Endostatin …

This work presents a mixed-signal physical-compu-tation-electronics for monitoring three
vital signs; namely heart rate, blood pressure, and blood oxygen saturation; from …

The natriuretic peptide (NP) system, which includes atrial natriuretic peptide, B-type
natriuretic peptide, and C-type natriuretic peptide, has an important role in cardiovascular …

Nowadays, the problem of preventing acute heart failure (AHF) in patients with ST-elevation
myocardial infarction (STEMI) and preserved left-ventricular ejection fraction (pLVEF) is still …

Heart failure (HF) has become a global public health problem due to its unclear
pathogenesis. Our previous studies have found that RNA oxidation is associated with the …